an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with TECH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then TECH could also see price increases.
Ticker / NAME | Correlation To CTMX | 1D Price Change % | ||
---|---|---|---|---|
CTMX | 100% | -0.99% | ||
TECH - CTMX | 41% Loosely correlated | -4.46% | ||
PYXS - CTMX | 39% Loosely correlated | N/A | ||
BCAB - CTMX | 39% Loosely correlated | -14.07% | ||
CRBU - CTMX | 37% Loosely correlated | -5.00% | ||
ABOS - CTMX | 36% Loosely correlated | +3.16% | ||
More |
Ticker / NAME | Correlation To CTMX | 1D Price Change % |
---|---|---|
CTMX | 100% | -0.99% |
therapy theme (23 stocks) | 29% Poorly correlated | -3.44% |
cancer theme (82 stocks) | 28% Poorly correlated | -2.35% |
biopharmaceuticals theme (50 stocks) | 25% Poorly correlated | -2.60% |
drugs theme (254 stocks) | 23% Poorly correlated | -1.67% |
treatment theme (56 stocks) | 18% Poorly correlated | -1.02% |
More |